Search
for
Sort by
Research 511–540 of 1000+
- Characterization and Management of Androgenetic Alopecia in Transgender and Gender-Diverse Individuals: A Narrative Review
- Standardization of Clinical Photos for Tracking Management of Hair Loss in Dermatology Clinics
- Actualización en el tratamiento de la tricotilomanía
- Impact of Finasteride and Dutasteride in Beard Thickness in Men With Androgenetic Alopecia: A 453-patient Retrospective Trial
- Exploring The Role of Shirodhara In Alleviating Post-Covid Psychological Symptoms.
- The risk of psychiatric disorders in finasteride users with benign prostatic hyperplasia and androgenetic alopecia: A population‐based case–control study
- Actualización en el tratamiento de la tricotilomanía
- Scalp Reconstruction
- MON-014 Evaluation of Healthcare of Gender-Dysphoric Veterans in the Veterans Affairs Northern California Health Care System (VANCHCS)
- Correction
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study
- Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
- What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
- 5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia
- Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
- The Alopecia Areata Severity and Morbidity Index (ASAMI) Study
- Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)*
- Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster
- Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes
- Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
- SULT1A1 (Minoxidil Sulfotransferase) enzyme booster significantly improves response to topical minoxidil for hair regrowth
- Novel “After Minoxidil” spray improves topical minoxidil compliance and hair style manageability
- Hair Transplant: Patient Candidacy, Medical Optimization, and Surgical Considerations
- Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development
- Chronological ageing of human hair keratin fibres